PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer

This study has been terminated.
(Sponsor withdrawal of funding)
Sponsor:
Collaborator:
GE Healthcare
Information provided by (Responsible Party):
The Methodist Hospital System
ClinicalTrials.gov Identifier:
NCT02067416
First received: February 17, 2014
Last updated: October 7, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)